Nonresected Non-Small-Cell Lung Cancer in Stages I Through IIIB: Accelerated, Twice-Daily, High-Dose Radiotherapy-A Prospective Phase I/II Trial With Long-Term Follow-Up

This Phase I/II trial with long-term follow-up shows low toxicity with promising results for survival and locoregional tumor control.